Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.18B |
| 2 |
Medtronic
MDT
|
+$2.06B |
| 3 |
Microsoft
MSFT
|
+$1.61B |
| 4 |
Procter & Gamble
PG
|
+$1.47B |
| 5 |
UBS Group
UBS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.42B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$2.34B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$930M |
| 4 |
Apple
AAPL
|
+$637M |
| 5 |
SWY
SAFEWAY INC
SWY
|
+$620M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.67% |
| 2 | Technology | 13.6% |
| 3 | Financials | 13.57% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Destination XL Group
DXLG
$35.4M
| $7.3M | ﹤0.01% |
1,477,903
+70,522
| +5% | +$348K |
|
|
SSNI
2802
DELISTED
Silver Spring Networks, Inc.
SSNI
| $7.29M | ﹤0.01% |
815,738
+159,477
| +24% | +$1.38M |
|
2803
Pathward Financial
CASH
$1.8B
| $7.27M | ﹤0.01% |
549,036
+7,215
| +1% | +$85.3K |
|
2804
Ocular Therapeutix
OCUL
$2.02B
| $7.26M | ﹤0.01% |
173,002
+98,663
| +133% | +$3.24M |
|
|
MVNR
2805
DELISTED
MAVENIR SYS INC COM STK (DE)
MVNR
| $7.23M | ﹤0.01% |
407,586
+108,041
| +36% | +$1.62M |
|
|
CDMO
2806
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $7.23M | ﹤0.01% |
765,031
+33,406
| +5% | +$322K |
|
|
MTEM
2807
DELISTED
Molecular Templates, Inc.
MTEM
| $7.22M | ﹤0.01% |
10,773
+1,492
| +16% | +$982K |
|
2808
Lineage Cell Therapeutics
LCTX
$278M
| $7.21M | ﹤0.01% |
1,798,535
+56,513
| +3% | +$196K |
|
|
HEOP
2809
DELISTED
Heritage Oaks Bancorp
HEOP
| $7.21M | ﹤0.01% |
868,034
+59,796
| +7% | +$482K |
|
2810
Miller Industries
MLR
$619M
| $7.19M | ﹤0.01% |
293,325
+854
| +0.3% | +$18.3K |
|
|
ATHX
2811
DELISTED
Athersys, Inc. Common Stock
ATHX
| $7.19M | ﹤0.01% |
99,820
+4,678
| +5% | +$283K |
|
|
NAVB
2812
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $7.18M | ﹤0.01% |
225,736
+15,149
| +7% | +$513K |
|
|
DRNA
2813
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $7.18M | ﹤0.01% |
298,601
+60,807
| +26% | +$1.37M |
|
|
EXAC
2814
DELISTED
Exactech Inc
EXAC
| $7.17M | ﹤0.01% |
279,660
+7,595
| +3% | +$175K |
|
|
WG
2815
DELISTED
Willbros Group
WG
| $7.13M | ﹤0.01% |
2,153,781
+141,384
| +7% | +$774K |
|
|
ZIXI
2816
DELISTED
Zix Corporation
ZIXI
| $7.12M | ﹤0.01% |
1,811,294
+2,675
| +0.1% | +$10.1K |
|
|
SQBG
2817
DELISTED
Sequential Brands Group, Inc.
SQBG
| $7.11M | ﹤0.01% |
16,606
+2,465
| +17% | +$1.04M |
|
2818
Culp Inc
CULP
$44.1M
| $7.1M | ﹤0.01% |
265,529
+20,628
| +8% | +$467K |
|
|
AEPI
2819
DELISTED
AEP Industries Inc
AEPI
| $7.09M | ﹤0.01% |
128,861
+3,758
| +3% | +$197K |
|
|
BBQ
2820
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
| $7.08M | ﹤0.01% |
248,609
-28,686
| -10% | -$850K |
|
2821
eHealth
EHTH
$43.9M
| $7.08M | ﹤0.01% |
755,047
+44,276
| +6% | +$529K |
|
|
PRTK
2822
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $7.08M | ﹤0.01% |
226,387
+7,633
| +3% | +$219K |
|
|
CGRN
2823
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $7.06M | ﹤0.01% |
54,328
+1,975
| +4% | +$271K |
|
|
CIVI
2824
DELISTED
Civitas Solutions, Inc.
CIVI
| $7.02M | ﹤0.01% |
335,036
+55,442
| +20% | +$1.06M |
|
|
DTLK
2825
DELISTED
Datalink Corp
DTLK
| $7.01M | ﹤0.01% |
582,182
+2,386
| +0.4% | +$28.6K |
|
Similar funds
Vanguard Group's Q1 2015 Portfolio in Review
As of Q1 2015, Vanguard Group held 4,228 positions worth $1.47T, up 6.2% from $1.39T the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Vanguard Group deployed $66B of net new capital in Q1 2015, opening 181 new positions and adding to 3,456 existing holdings. Its largest new stake was UBS Group: 57,940,325 shares worth $1.09B.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $637M trimmed.
- Vanguard Group's largest Q1 2015 buy was UBS Group: 57,940,325 shares worth $1.09B.
- Vanguard Group added most to Allergan plc in Q1 2015, an estimated $2.18B increase.
- Vanguard Group's biggest Q1 2015 reduction was Apple, cutting an estimated $637M.
- Vanguard Group fully exited Allergan Inc in Q1 2015, selling an estimated $3.42B.
- Vanguard Group's ten largest holdings make up 12% of its $1.47T portfolio in Q1 2015.
- Vanguard Group opened 181 new positions and closed 75 in Q1 2015.
- Vanguard Group's portfolio value rose 6.2% quarter-over-quarter to $1.47T.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.